Owner Janssen Pharmaceuticals, Inc

Inventors Wu, Tongfei; Gijsen, Henricus Jacobus Maria; Rombouts, Frederik Jan Rita; Bischoff, Francois Paul; Berthelot, Didier Jean-Claude; Oehlrich, Daniel; De Cleyn, Michel Anna Jozef; Pieters, Serge Maria Aloysius; Minne, Garrett Berlond; Velter, Adriana Ingrid; Van Brandt, Sven Franciscus Anna; Surkyn, Michel

Agent Shelston IP

Pub. Number AU-A-2010272578

PCT Pub. Number WO2011/006903

Priority 09165585.2 15.07.09 EP; 10164625.5 01.06.10 EP

Filing date 13 July 2010

Wipo publication date 20 January 2011

C07D 233/60 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4178 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/4439 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms